Invention Grant
- Patent Title: IP-10 antibodies and their uses
- Patent Title (中): IP-10抗体及其用途
-
Application No.: US13478786Application Date: 2012-05-23
-
Publication No.: US08945546B2Publication Date: 2015-02-03
- Inventor: Shrikant Deshpande , Haichun Huang , Mohan Srinivasan , Josephine M. Cardarelli , Changyu Wang , David Passmore , Vangipuram Rangan , Thomas E. Lane , Hans S. Keirstead , Michael T. Liu
- Applicant: Shrikant Deshpande , Haichun Huang , Mohan Srinivasan , Josephine M. Cardarelli , Changyu Wang , David Passmore , Vangipuram Rangan , Thomas E. Lane , Hans S. Keirstead , Michael T. Liu
- Applicant Address: US NJ Princeton
- Assignee: Medarex, L.L.C.
- Current Assignee: Medarex, L.L.C.
- Current Assignee Address: US NJ Princeton
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Jeanne M. DiGiorgio
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/40 ; C07K14/52 ; C07K16/24 ; A61K39/00
Abstract:
The present invention provides isolated monoclonal antibodies, particularly human antibodies, that bind to IP-10 with high affinity, inhibit the binding of IP-10 to its receptor, inhibit IP-10-induced calcium flux and inhibit IP-10-induced cell migration. Nucleic acid molecules encoding the antibodies of the invention, expression vectors, host cells and methods for expressing the antibodies of the invention are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The invention also provides methods for inhibiting IP-10 activity using the antibodies of the invention, including methods for treating various inflammatory and autoimmune diseases.
Public/Granted literature
- US20120230998A1 IP-10 ANTIBODIES AND THEIR USES Public/Granted day:2012-09-13
Information query
